NCT02585596View on ClinicalTrials.gov

A Phase II Clinical Trial of YH23537 in Patients With Chronic Periodontal Disease.

PHASE2CompletedINTERVENTIONAL
Enrollment

275

Participants

Timeline

Start Date

December 16, 2015

Primary Completion Date

December 28, 2016

Study Completion Date

June 27, 2017

Conditions
Chronic Periodontitis
Interventions
DRUG

YH23537 1000mg/day

YH23537 500mg 2 tab

DRUG

YH23537 2000mg/day

YH23537 500mg 4 tab

DRUG

YH23537 3000mg/day

YH23537 500mg 6 tab

DRUG

placebo

YH23537 500mg tab placebo

Trial Locations (1)

Unknown

Incheol Rhyu, Seoul

All Listed Sponsors
lead

Yuhan Corporation

INDUSTRY

NCT02585596 - A Phase II Clinical Trial of YH23537 in Patients With Chronic Periodontal Disease. | Biotech Hunter | Biotech Hunter